Pharmaceutical services in an HIV clinic

被引:28
作者
Geletko, SM
Poulakos, MN
机构
[1] Vet Affairs Med Ctr, Dept Pharm Practice, Providence, RI 02908 USA
[2] Univ Rhode Isl, Coll Pharm, Dept Pharm Practice, Kingston, RI 02881 USA
[3] Nova SE Univ, Coll Pharm, Ft Lauderdale, FL 33314 USA
[4] Broward Gen Med Ctr, Ft Lauderdale, FL USA
关键词
ambulatory care; antiretroviral agents; clinical pharmacists; clinical pharmacy; compliance; HIV infections; interventions; pharmaceutical care; pharmaceutical services;
D O I
10.1093/ajhp/59.8.709
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pharmaceutical-related interventions in a pharmacist-directed human immunodeficiency virus (HIV) clinic were Characterized. Intervention types, clinical significance, and expected outcomes were adapted from the literature. Pharmacists' interventions were recorded on a spreadsheet, and two came into agreement to ensure consistency of categorization. Intervention types, clinical significance, expected outcomes, and types of therapy precipitating interventions were summarized. The number of patients seen was totaled, and the number of interventions per patient per visit was calculated. The average number of medications and CD4+ lymphocyte counts throughout the study were obtained through the Veterans Affairs Medical Center computer patient record system. A total of 70 patients received pharmaceutical services during the four-year period. Each patient received an average of seven medications and two interventions. The most common interventions were medication counseling (39%), recommendations of monitoring parameters (17%), and prescription processing (9%). The majority of interventions were clinically significant (89%) and enhanced treatment efficacy (62%). The percentage of antiretroviral therapy-related and HIV-related interventions fluctuated over the study period, while the percentage of non-HIV-related interventions increased. Pharmacists' interventions and direct patient care at an HIV clinic effectively ensured patient adherence to treatment and provided clinical benefits for patients.
引用
收藏
页码:709 / 713
页数:5
相关论文
共 20 条
[1]   Factors affecting adherence to antiretroviral therapy [J].
Chesney, MA .
CLINICAL INFECTIOUS DISEASES, 2000, 30 :S171-S176
[2]  
Colombo J, 1997, J Am Pharm Assoc (Wash), VNS37, P581
[3]   Pharmacists' provision of continuity of care to patients with human immunodeficiency virus infection [J].
Foisy, MM ;
Tseng, A ;
Blaikie, N .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (09) :1013-1017
[4]  
Friedland GH, 1999, AIDS, V13, pS61
[5]   HIV pharmacotherapy clinic [J].
Fung, HB ;
Pecini, RA ;
Brown, ST .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (09) :955-956
[6]  
HADIGAN C, 2001, AIDS CLIN CARE, V13, P13
[7]   Glucose disorders associated with HIV and its drug therapy [J].
Hardy, H ;
Esch, LD ;
Morse, GD .
ANNALS OF PHARMACOTHERAPY, 2001, 35 (03) :343-351
[8]   EVALUATION OF THE CONTRIBUTION OF CLINICAL PHARMACISTS - INPATIENT CARE AND COST REDUCTION [J].
HATOUM, HT ;
HUTCHINSON, RA ;
WITTE, KW ;
NEWBY, GP .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1988, 22 (03) :252-259
[9]   Helping HIV-infected patients at the clinic [J].
Hicks, AR .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (07) :661-663
[10]   Resistance to protease inhibitors [J].
Miller, V .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 :S34-S50